Yahoo Search Busca da Web

Resultado da Busca

  1. en.wikipedia.org › wiki › Stewart_ColeStewart Cole - Wikipedia

    Sir Stewart Thomas Cole KCMG FRS (born 1955) is a British/French microbiologist. He was the Director General of the Pasteur Institute since January 2018 to December 2023.

  2. 30 de abr. de 2018 · Stewart Cole is an internationally renowned scientist and Professor of Microbial Pathogenesis. Since January 2 nd, 2018, he is the President of the Institut Pasteur.

  3. Stewart Cole is a literary scholar working at the intersections of ecocriticism, animal studies, utopian/dystopian studies, and modern British and Irish literatures. His book The Poetics of Utopia: Shadows of Futurity in Yeats and Auden was published by Bloomsbury in the spring of 2023.

  4. 9 de jan. de 2024 · Sir Stewart Cole, KCMG, FRS has joined the Ineos Oxford Institute for antimicrobial research (IOI) as Executive Chair. The IOI is a world-leading centre of research, training, and education in the field of antimicrobial resistance (AMR) based at the University of Oxford.

  5. 23 de abr. de 2021 · Biography. Stewart Cole, the Institut Pasteur's President since 2018, is a world-renowned scientist and professor of microbial pathogenesis. Between 2007 and 2017, he was Professor and Director of the Global Health Institute at the Swiss Federal Institute of Technology (EPFL) – a world-leading education and research center.

  6. 2013. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. AS Pym, P Brodin, R Brosch, M Huerre, ST Cole. Molecular microbiology 46 (3), 709-717. , 2002. 941. 2002. Multidrug-resistant tuberculosis and culture conversion with bedaquiline.

  7. Stewart Cole achieved international recognition for his leadership of the project to sequence the genome of the bacterium responsible for tuberculosis, successfully completed in 1998. It was the first major pathogen to be sequenced, and the resulting data continues to furnish abundant opportunities to develop a new generation of treatments.